Item Type | Name |
Academic Article
|
Costs, charges, and reimbursements for persons with sickle cell disease.
|
Academic Article
|
Transcranial Doppler ultrasonography and neurocognitive functioning in children with sickle cell disease.
|
Academic Article
|
Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome.
|
Academic Article
|
Prevention and management of strokes in patients with sickle cell disease.
|
Academic Article
|
Radiographic predictors of neurocognitive functioning in pediatric Sickle Cell disease.
|
Academic Article
|
Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease.
|
Academic Article
|
Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome.
|
Academic Article
|
Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease.
|
Academic Article
|
Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease.
|
Academic Article
|
Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels.
|
Academic Article
|
Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial.
|
Academic Article
|
Hematopoietic stem-cell transplantation for adults with sickle cell disease.
|
Academic Article
|
Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
|
Academic Article
|
Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events.
|
Academic Article
|
Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II.
|
Academic Article
|
Intracranial blood flow velocities in patients with sickle cell disease and ß-thalassemia intermedia.
|
Academic Article
|
Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion.
|
Academic Article
|
Neurologic complications following bone marrow transplantation for sickle cell disease.
|
Academic Article
|
Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group.
|
Academic Article
|
Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study.
|
Academic Article
|
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.
|
Academic Article
|
Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering.
|
Academic Article
|
Vascular at-risk genotypes and disease severity in Lebanese sickle cell disease patients.
|
Academic Article
|
Y-chromosome R-M343 African lineages and sickle cell disease reveal structured assimilation in Lebanon.
|
Academic Article
|
Stem-cell transplantation in children and adults with sickle cell disease: an update.
|
Academic Article
|
Cerebral infarction in children with sickle cell disease: a concise overview.
|
Academic Article
|
Pulmonary complications of sickle cell disease.
|
Academic Article
|
Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.
|
Academic Article
|
A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.
|
Academic Article
|
Impact of laparoscopic cholecystectomy on the management of cholelithiasis in children with sickle cell disease.
|
Academic Article
|
Bone marrow transplantation for sickle cell disease. The United States experience.
|
Academic Article
|
Ticagrelor does not impact patient-reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study.
|
Academic Article
|
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
|
Academic Article
|
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease.
|
Academic Article
|
A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease.
|
Academic Article
|
Educational intervention to improve the health outcomes of children with sickle cell disease.
|
Academic Article
|
The Daily Experiences of Adolescents in Lebanon With Sickle Cell Disease.
|
Academic Article
|
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.
|
Academic Article
|
Sickle cell disease.
|
Academic Article
|
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
|
Academic Article
|
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
|
Academic Article
|
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3).
|
Academic Article
|
Emergence of gram-negative organisms as the cause of infections in patients with sickle cell disease.
|
Academic Article
|
Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
|
Academic Article
|
Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged <24 months.
|
Academic Article
|
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
|
Academic Article
|
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
|
Academic Article
|
Paediatric to adult transition care for patients with sickle cell disease: a global perspective.
|
Academic Article
|
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
|
Academic Article
|
Standard management of sickle cell disease complications.
|
Academic Article
|
Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years.
|
Academic Article
|
Voxelotor for the treatment of sickle cell disease in pediatric patients.
|
Academic Article
|
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study.
|